Sharath Reddy Annam

Sharath Reddy Annam

Auto-generated profile, based on publicly available information

Sharath Reddy Annam

Department of Cardiology, Medicover Hospitals, Hyderabad, Telangana, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Indian Pacing and Electrophysiology Journal
Verified
Journal Article
Open access
KNKumar Narayanan
Kumar Narayanan
MOMohammed Omer
Mohammed Omer
MAMohammed Arif
Mohammed Arif
PSPapani Sridhar
Papani Sridhar
NANitin Annarapu
Nitin Annarapu
PEPadmakumar Ea
Padmakumar Ea
Left-sided ablation, targeting left inferior AV nodal extensions, is thought to be necessary for success in a small proportion of atrioventricular nodal re-entrant tachycardia (AVNRT) ablations; however Indian data are scarce in this regard. Consecutive cases of AVNRT undergoing slow pathway ablation in a single centre over an 18-month period were retrospectively analyzed. Left-sided ablation at the posteroseptal mitral annulus was performed if right-sided ablation failed to abolish AVNRT. From January 2017 to June 2018, out of 215 consecutive supraventricular tachycardia (SVT) cases, 154 (71.6%) were AVNRT (47.1 ± 13.1 years, 46.1% male). Trans-septal ablation was required in 5 (3.2%) cases (mean age 48.8 ± 9.4 years; 4 female, 1 male); all with typical (slow-fast) form of AVNRT. Compared with cases needing only right-sided ablation, radiofrequency time (50.8 ± 16.9 vs. 9.9 ± 8.5 min; p = 0.005) and procedure time (166.0 ± 35.0 vs 79.6 ± 35.9 min; p = 0.004) were significantly longer for trans-septal cases, while baseline intervals and tachycardia cycle length were not significantly different. Junctional ectopy was seen in only 2 of the 5 cases during left-sided ablation, but acute success (non-inducibility) was obtained in 3 cases. There were no instances of AV block. Over mean follow-up of 12.2 ± 4.0 months, clinical recurrence of AVNRT occurred in one case, while others remained arrhythmia-free without medication. Left-sided ablation was required in a small proportion of AVNRT ablations. Trans-septal approach targeting the posteroseptal mitral annulus was safe and yielded good mid-term clinical success.

1 June 2020 in EP Europace
Verified
Journal Article
Closed access
PDF file
RZR Zhang
R Zhang
IFI T Fazmin
I T Fazmin
APA Porto
A Porto
KDK Divulwewa
K Divulwewa
ARA Reddy
A Reddy
CMC A Martin
C A Martin
Introduction: Little is known regarding the aetiology or outcome of atrial fibrillation (AF) occurring in young adults. This retrospective analysis was performed to explore the demographics and efficacy of AF ablation in this population. Methods: Patients were included who had undergone ≥1 AF ablation under the age of 40 between 2006-2018. Recurrence was defined as return of either documented AF or previous symptoms for >30s following a 3-month blanking period. Initial exploratory co-variates were included in a univariate analysis and those terms with P-value of <0.1 were then used to generate a Cox proportional-hazards multivariate model. Results: 124 patients (33.6 ± 4.7 yrs, 77% men), initially presenting with paroxysmal AF (pAF; n = 97) or persistent AF (n = 27), underwent 175 AF ablation procedures. 22.6% (n = 28) also had atrial flutter. Time from symptom onset to first ablation was 50.7 ± 46.2 months. Relevant cardiovascular-related demographics were analysed: hypertension in 8.9% (n = 11); diabetes in 1.6% (n = 2); positive family history of AF in 12.9% (n = 16); and family history of sudden cardiac death in 2.4% (n = 3). Mean CHA2DS2-VASc score was 0.35. Of those patients with documented echocardiogram imaging (n = 91), 26.4% (n = 24) had LA dilatation and 6.6% (n = 6) had LV dysfunction. Patients with LA dilatation underwent more ablations (2.3 ± 0.3) compared to controls (1.5 ± 0.1; p < 0.001). Ablation strategy was pulmonary vein isolation (PVI) only in 67.2% (n = 119), with additional ablation in the remaining: roof line in 18.9% (n = 33); cavotricuspid isthmus line in 13.1% (n = 23); mitral isthmus line in 2.3% (n = 4); superior vena cava isolation in 2.3% (n = 4); complex fractionated atrial electrograms in 14.9% (n = 26). Mean procedure time was 155 ± 41 min, mean ablation time was 1657 ± 991 s and mean fluoroscopy time was 32.6 ± 23.4 min. General anaesthesia was used in 43.4% (n = 76). Complications included femoral haematoma (n = 2), tamponade (n = 1) and pulmonary vein stenosis (n = 2). 90 days of follow-up was available for 137 procedures performed for pAF (n = 105) and persistent AF (n = 32). For pAF, overall recurrence was 61.9% for first ablations and 62.9% overall. Recurrence was 56.3% for persistent AF. Factors significantly associated with increased AF recurrence in univariate analysis were: male gender (hazard ratio (HR) 2.3, 95% confidence interval (CI): 1.2-4.4, p = 0.011), hypertension (HR 0.5, CI: 0.2-1.1, p = 0.067), family history of sudden cardiac death (HR 6.8, CI: 1.6-29.0 , p = 0.010) and enlarged LA size (HR 2.2, CI: 1.3-3.6, p = 0.003). In multivariate analysis, the only significant predictor of poor outcome was enlarged LA size (HR 2.0, 95% CI: 1.2-3.5, p = 0.011). Conclusions: Young patients with AF may have structurally abnormal hearts, and therefore do not only present with lone AF. LA size may be used as a predictor for success. Surveillance imaging may be useful to detect future structural change, which will be the subject of future prospective studies. Abstract Figure. AF ablation recurrence in young adults

1 June 2020 in EP Europace
Verified
Journal Article
Closed access
PDF file
IFI T Fazmin
I T Fazmin
RZR Y Zhang
R Y Zhang
APA Porto
A Porto
KDK Divulwewa
K Divulwewa
BNB Di Nubila
B Di Nubila
CMC A Martin
C A Martin
Background: Catheter ablation is an important adjunct to device implantation for secondary prevention of ventricular tachycardia (VT). However, several factors may influence the success of ablations in terms of long-term freedom from VT recurrence. A thus far little examined factor is the use of general anaesthetic (GA) versus conscious sedation during the procedure, which has been shown to improve outcomes in persistent atrial fibrillation (AF) ablation. Methods: Patients with structural heart disease VT undergoing ablations from January 2015 to March 2019 were retrospectively followed up at a single centre. End points were recurrent VT or device therapy (shock or anti-tachycardia pacing) at one year. Hazard ratios (HR) were generated using a multivariate Cox-regression proportional hazards model including variables of age at ablation, sex, amiodarone use at time of ablation, scar age, left ventricular ejection fraction, use of GA, and diagnosis of: diabetes mellitus (DM), hypertension (HTN), renal impairment or AF. Results: 79 patients (74 male, mean age 68.2+/- 10.3 years) were included. A substrate-based strategy of late potential ablation was employed. 69 had ischaemic and 10 had non-ischaemic cardiomyopathy. Mean scar age was 13.8 +/- 9.8 years; EF was 40-50% in 27 patients, 30-40% in 26 and < 30% in 26. 37 patients had implantable cardioverter defibrillators and 30 had cardiac resynchronisation therapy (CRT) defibrillator devices, 1 had a CRT- pacemaker device and 4 had dual chamber pacemakers. Comorbidities were: DM (16), HTN (31), renal impairment (13), AF (31). 62 patients (79.5%) were on amiodarone at the time of ablation. Mean procedure duration was 234.8 +/- 44.5 min and mean radiofrequency energy application time was 2247 +/- 862 s. 61 were first procedures and 18 were repeat procedures. One patient suffered a complication of groin haematoma. 62 patients (78.5%) underwent VT ablation under GA and 17 (21.5%) under sedation of midazolam and fentanyl. Patient characteristics did not differ between groups. Significant factors which increased freedom from VT recurrence or device therapy were HTN (88.9% vs 59.4%, HR 0.72, 95% confidence interval (CI): 0.007-0.75, p= 0.028), amiodarone treatment (50.0% vs 76.3%, HR 0.036, 95% CI: 0.003-0.404, p = 0.036) and ablation under GA rather than sedation (50.0% vs 75.0%, HR 0.055, 95% CI: 0.006-0.495, p = 0.01) (Fig 1). Conclusions: In patients with structural heart disease undergoing VT ablation, outcomes are improved with the use of GA over conscious sedation. Abstract Figure 1

31 December 2023 in Indian Journal of Clinical Cardiology
Verified
Journal Article
Open access
ARA. Sharath Reddy
A. Sharath Reddy
MPM. Premchand
M. Premchand
GKG. Anil Krishna
G. Anil Krishna
LSLokanath Seepana
Lokanath Seepana
GRG. Damodhar Reddy
G. Damodhar Reddy
HAHansika
Hansika
Coronary artery calcification impacts outcomes after percutaneous coronary interventions owing to stent under expansion causing increased risk of stent thrombosis and restenosis. Therefore, adequate calcium modification before stent placement is the key to get desired outcomes in the patients with coronary artery calcification. Many devices are available for calcium modification, which includes orbital or rotational atherectomy, cutting balloon, scoring balloon, and intravascular lithotripsy. All these techniques have inherent risks of complications, such as coronary dissection, perforation, and slow or no reflow. We report a case of intravascular lithotripsy in calcified proximal left circumflex artery (LCX) lesion in a 63-year-old female leading to the left anterior descending artery (LAD) with no flow and ischemic ventricular tachycardia requiring DC cardioversion. Intravascular ultrasound from LAD revealed subintimal hematoma from ostium to mid LAD with intimal flap continuation into ostio-proximal LCX. The intimal flap in LAD has not showed any entry or exit tears which might increase the possibility of intramural hematoma shift to adjacent areas and branches leading to no reflow. Hence, cutting balloon fenestration of the intimal flap, followed by left main coronary artery bifurcation stenting was done to get a good result with flowing distal branches.

6 August 2025 in JACC: Case Reports
Verified
Journal Article
Open access
SASharath Reddy Annam
Sharath Reddy Annam
AGAnil Krishna Gundala
Anil Krishna Gundala
MNMohammed Jamaluddin Naveed
Mohammed Jamaluddin Naveed
NNNitin Naik
Nitin Naik
LSLokanath Seepana
Lokanath Seepana
Iatrogenic ascending aortic pseudoaneurysms are a rare but life-threatening complication of reconstructive cardiovascular surgery. Such aneurysms can result in rupture, thrombosis, or distal embolization. Surgical repair of such pseudoaneurysms is associated with high morbidity and mortality. We present a rare case of device closure of saccular pseudoaneurysm of the ascending aorta in a patient with valve-sparing Bentall surgery for acute type A aortic dissection.